Stifel Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $42.5M | Sell |
1,156,481
-111,219
| -9% | -$5.27M | 0.04% | 403 |
|
|
2025
Q4 | $64.5M | Buy |
1,267,700
+348,328
| +38% | +$17.8M | 0.06% | 317 |
|
|
2025
Q3 | $51M | Sell |
919,372
-227,577
| -20% | -$13.3M | 0.05% | 358 |
|
|
2025
Q2 | $79.2M | Sell |
1,146,949
-40,568
| -3% | -$2.76M | 0.08% | 260 |
|
|
2025
Q1 | $82.5M | Sell |
1,187,517
-329,650
| -22% | -$27.2M | 0.09% | 239 |
|
|
2024
Q4 | $131M | Sell |
1,517,167
-240,123
| -14% | -$26M | 0.14% | 160 |
|
|
2024
Q3 | $209M | Sell |
1,757,290
-14,742
| -0.8% | -$1.97M | 0.22% | 106 |
|
|
2024
Q2 | $253M | Buy |
1,772,032
+74,716
| +4% | +$9.9M | 0.28% | 80 |
|
|
2024
Q1 | $218M | Buy |
1,697,316
+72,189
| +4% | +$8.59M | 0.25% | 92 |
|
|
2023
Q4 | $168M | Buy |
1,625,127
+99,677
| +7% | +$9.86M | 0.21% | 109 |
|
|
2023
Q3 | $139M | Buy |
1,525,450
+34,770
| +2% | +$3.06M | 0.2% | 115 |
|
|
2023
Q2 | $121M | Sell |
1,490,680
-514,998
| -26% | -$42.1M | 0.17% | 140 |
|
|
2023
Q1 | $160M | Sell |
2,005,678
-413,146
| -17% | -$29.3M | 0.23% | 102 |
|
|
2022
Q4 | $164M | Sell |
2,418,824
-25,310
| -1% | -$1.48M | 0.25% | 92 |
|
|
2022
Q3 | $122M | Sell |
2,444,134
-35,556
| -1% | -$1.9M | 0.2% | 119 |
|
|
2022
Q2 | $138M | Buy |
2,479,690
+134,324
| +6% | +$7.45M | 0.22% | 107 |
|
|
2022
Q1 | $130M | Buy |
2,345,366
+259,788
| +12% | +$13.3M | 0.18% | 133 |
|
|
2021
Q4 | $117M | Buy |
2,085,578
+60,016
| +3% | +$3.25M | 0.15% | 151 |
|
|
2021
Q3 | $97.2M | Buy |
2,025,562
+84,398
| +4% | +$4.08M | 0.14% | 156 |
|
|
2021
Q2 | $81.3M | Buy |
1,941,164
+70,712
| +4% | +$2.74M | 0.12% | 176 |
|
|
2021
Q1 | $63.1M | Buy |
1,870,452
+267,598
| +17% | +$9.53M | 0.1% | 200 |
|
|
2020
Q4 | $56M | Buy |
1,602,854
+48,250
| +3% | +$1.67M | 0.1% | 203 |
|
|
2020
Q3 | $54M | Buy |
1,554,604
+24,934
| +2% | +$831K | 0.11% | 186 |
|
|
2020
Q2 | $50.1M | Buy |
1,529,670
+704,814
| +85% | +$22.5M | 0.12% | 184 |
|
|
2020
Q1 | $24.8M | Buy |
824,856
+198,788
| +32% | +$5.92M | 0.07% | 253 |
|
|
2019
Q4 | $18.1M | Buy |
626,068
+60,510
| +11% | +$1.68M | 0.04% | 388 |
|
|
2019
Q3 | $14.6M | Buy |
565,558
+53,848
| +11% | +$1.36M | 0.04% | 426 |
|
|
2019
Q2 | $13.1M | Sell |
511,710
-4,554
| -0.9% | -$113K | 0.03% | 470 |
|
|
2019
Q1 | $13.5M | Buy |
516,264
+33,578
| +7% | +$825K | 0.04% | 432 |
|
|
2018
Q4 | $11.1M | Sell |
482,686
-126,830
| -21% | -$2.82M | 0.04% | 458 |
|
|
2018
Q3 | $14.4M | Sell |
609,516
-53,436
| -8% | -$1.3M | 0.04% | 391 |
|
|
2018
Q2 | $15.3M | Sell |
662,952
-52,406
| -7% | -$1.25M | 0.05% | 391 |
|
|
2018
Q1 | $17.6M | Sell |
715,358
-11,804
| -2% | -$310K | 0.06% | 341 |
|
|
2017
Q4 | $19.5M | Buy |
727,162
+4,766
| +0.7% | +$121K | 0.06% | 310 |
|
|
2017
Q3 | $17.4M | Sell |
722,396
-23,542
| -3% | -$532K | 0.06% | 315 |
|
|
2017
Q2 | $16M | Buy |
745,938
+18,060
| +2% | +$364K | 0.06% | 316 |
|
|
2017
Q1 | $12.5M | Sell |
727,878
-239,608
| -25% | -$4.17M | 0.05% | 380 |
|
|
2016
Q4 | $17.4M | Sell |
967,486
-291,040
| -23% | -$5.28M | 0.07% | 277 |
|
|
2016
Q3 | $26.2M | Sell |
1,258,526
-409,776
| -25% | -$10.2M | 0.12% | 192 |
|
|
2016
Q2 | $44.9M | Sell |
1,668,302
-26,756
| -2% | -$734K | 0.21% | 114 |
|
|
2016
Q1 | $45.9M | Buy |
1,695,058
+23,454
| +1% | +$628K | 0.24% | 99 |
|
|
2015
Q4 | $48.5M | Sell |
1,671,604
-164,056
| -9% | -$4.54M | 0.25% | 103 |
|
|
2015
Q3 | $49.8M | Sell |
1,835,660
-33,222
| -2% | -$941K | 0.28% | 91 |
|
|
2015
Q2 | $51M | Buy |
1,868,882
+143,616
| +8% | +$4.04M | 0.26% | 95 |
|
|
2015
Q1 | $46M | Buy |
1,725,266
+52,034
| +3% | +$1.2M | 0.25% | 98 |
|
|
2014
Q4 | $35.4M | Buy |
1,673,232
+1,547,536
| +1,231% | +$34.6M | 0.2% | 133 |
|
|
2014
Q3 | $2.99M | Buy |
125,696
+61,452
| +96% | +$1.41M | 0.03% | 637 |
|
|
2014
Q2 | $1.48M | Buy |
64,244
+10,512
| +20% | +$232K | 0.01% | 910 |
|
|
2014
Q1 | $1.23M | Buy |
+53,732
| New | +$1.14M | 0.01% | 957 |
|
Other funds holding NVO
DAM
F
Stifel Financial's NVO Position: Q1 2026 in Review
Stifel Financial reduced its Novo Nordisk (NVO) stake by 8.8% in Q1 2026, selling an estimated $5.27M and leaving 1,156,481 shares worth $42.5M. The position accounts for 0.04% of the portfolio, ranked #403.
Stifel Financial first reported a position in NVO in Q1 2014 and has held it in 49 quarters since. The position peaked at $253M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Stifel Financial held 1,156,481 shares of Novo Nordisk worth $42.5M as of Q1 2026.
- Stifel Financial sold 111,219 Novo Nordisk shares in Q1 2026, an estimated $5.27M.
- Novo Nordisk made up 0.04% of Stifel Financial's portfolio in Q1 2026, its #403 holding.
- Stifel Financial first reported a position in Novo Nordisk in Q1 2014 and has held it in 49 quarters since.
- Stifel Financial's Novo Nordisk position peaked at $253M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.